Form 4 for VBIO Valion Bio, Inc.
Accepted 2025-12-22 00:00:00 ET · period of report 2025-12-18 · accession 0001683168-25-009305 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-22 | 2025-12-18 | VBIO | Ernst Jennifer | CEO, Dir | F - Tax | $1.87 | -5,262 | 32.7K | -14% | -$9,840 |
| D | 2025-12-22 | 2025-12-18 | VBIO | Ernst Jennifer | CEO, Dir | M - OptEx | — | +14.7K | 38.0K | +63% | — |
| D | 2025-12-22 | 2025-12-18 | VBIO | Ernst Jennifer | CEO, Dir | M - OptEx | $0.00 | -14.7K | 14.7K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-18 | F | D | 5,262 | $1.87 | 32,691 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-18 | M | A | 14,706 | — | 37,953 | D | — | — | (F1) Each Restricted Stock Unit is convertible into one share of Common Stock. |
| 3 | Derivative | Restricted Stock Units | 2025-12-18 | M | D | 14,706 | $0.00 | 14,706 | D | — · — to — | 14,706 Common Stock | (F1) Each Restricted Stock Unit is convertible into one share of Common Stock. (F3) Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the date of grant, December 18, 2024 (the "Vesting Commencement Date"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date. |